Andromeda Biotech Ltd. Report issue

For profit Phase 3
Founded: Yavne Israel (2007)
Status: Acquired by Hyperion Therapeutics (2014) → now Amgen

Organization Overview

First Clinical Trial
2007
NCT00615264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

diapep277 (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 1